New products are live, and we’ve lowered prices across the catalog. Heads up - high demand means a 2–3 day shipping backlog. Free shipping on orders over $200!
Palm Beach Vitality

Sermorelin Pen

$140.00

Sermorelin 3 mL Pen

The Science, Simplified: Sermorelin is a synthetic 29-amino acid peptide corresponding to the biologically active N-terminal fragment of human growth hormone-releasing hormone (GHRH 1-29).

Product Specifications – Sermorelin 10 mg 3 mL Pen

  • Total Sermorelin: 10 mg
  • Volume: 3 mL pre-filled pen
  • Concentration: ≈3.33 mg/mL
  • Purity: Research-grade, third-party tested (COA available)
  • Format: Ready-to-use multi-dose pre-filled pen

Key Research Focus: Growth hormone release and GH axis research.

Physical Form & Solubility:

  • Appearance: Clear to slightly opalescent liquid
  • Solubility: Already in aqueous solution (acetate salt form for optimal solubility and stability). Highly soluble; no reconstitution required.

Pen Format Details: The 3 mL pre-filled pen is a sterile, multi-dose delivery system designed for precise, consistent dispensing of the research compound. It features a sealed cartridge, dial-a-dose mechanism for accurate volume control, and a fine-gauge needle interface. The pen is ready for immediate laboratory use with no mixing or transfer steps required. Each pen is labeled with total peptide content and lot-specific COA reference.

Stability & Handling Notes:

  • Refrigerated at 2–8°C (36–46°F). Practical shelf life is 4–6 weeks when protected from light and handled with aseptic technique.
  • Do not freeze. Avoid prolonged room-temperature exposure.
  • Discard after 6 weeks or if the solution becomes cloudy, discolored, or shows particulate matter.
  • Protect from light and moisture at all times.

Sermorelin Research Studies

Selected English-language peer-reviewed references for laboratory research context. Links open publisher or PubMed/PMC records.

Read the Sermorelin research overview

  1. Sermorelin: a better approach to management of adult-onset growth hormone insufficiency?PubMed 18046908
  2. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiencyPubMed 18031173
  3. A potentially effective drug for patients with recurrent glioma: sermorelinPubMed 33842627
  4. Growth during and after a trial of growth hormone releasing hormone 1-29 in children with idiopathic short stature or growth hormone neurosecretory dysfunctionPubMed 10905389
  5. Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapyPubMed 8772599
Sermorelin amino acid chain
Sermorelin — amino acid chain (N→C)